Perry Shen MD Professor of Surgery
Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast), Minimally Invasive Surgery
Professor of Surgery
Join to View Full Profile
Wfusom Watlington HallMedical Center BlvdWinston Salem, NC 27157
Dr. Shen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
John Wayne Cancer Institute1998 - 2000
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Surgery, 1993 - 1998
Johns Hopkins University School of MedicineInternship, Transitional Year, 1992 - 1993
Keck School of Medicine of the University of Southern CaliforniaClass of 1992
Certifications & Licensure
CA State Medical License 1993 - Present
NC State Medical License 2000 - 2025
FL State Medical License 2016 - 2018
American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
- Join now to see all
Clinical Trials
- Gene Expression Profiling in Normal Tissue and Tumor Tissue From Patients With Colon Cancer That Has Spread to the Liver, Lungs, or Peritoneum Start of enrollment: 2003 Sep 01
- Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
- Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?Christopher W Mangieri, Konstantinos I Votanopoulos, Perry Shen, Edward A Levine
Annals of Surgical Oncology. 2025-04-01 - Outcomes for Gastrectomy During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongastric Primaries: 30-Year Experience.Heidy Cos, Greg Russell, Kathleen Perry, Konstantinos I Votanopoulos, Edward A Levine
Journal of the American College of Surgeons. 2025-04-01 - ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, Is it Appropriate?Christopher W Mangieri, Konstantinos I Votanopoulos, Perry Shen, Edward A Levine
Annals of Surgical Oncology. 2025-03-04
Press Mentions
Study Finds Benefits to Second Peritoneal Mesothelioma SurgeryApril 13th, 2022- Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC)December 2nd, 2020
- Wake Forest Baptist May Awards and RecognitionsMay 15th, 2020
- Join now to see all
Committees
- Section Editor, Peritoneal Surface Malignancies, Journal of Surgical Oncology 2013 - Present
Professional Memberships
- Member
- Member
- American HepatoPancreatoBiliary AssociationMember
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
